Bafna Pharmaceuticals Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate

Standalone


Total Qtr Revenue cr	12.46	10.96	12.16	7.15	8.80
Other Income Qtr Cr	-0.67	0.03	0.59	0.30	-0.03
Operating Revenues Qtr	13.13	10.93	11.57	6.85	8.84
Loading chart...
Operating Expenses Qtr	8.89	10.70	11.94	9.72	8.65
Operating Profit Qtr	4.24	0.22	-0.38	-2.87	0.18
EBITDA Qtr Cr	2.73	-21.46	0.22	-2.56	0.15
Depreciation Qtr	0.52	1.00	0.72	1.02	0.75
Net Profit Qtr	0.32	-22.33	-0.59	-2.13	-1.28
Basic EPS Qtr	0.20	-94.39	-0.25	-0.90	-0.80

Open Demat Account